Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironobu Shibata

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2018
[Azacitidine treatment for acute myeloid leukemia with myelodysplasia-related changes during peritoneal dialysis]Takashi Omatsu, Kengo Udaka, Hironobu Shibata, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|August 29, 2024
[Aortic Valve Replacement Using Minimally Invasive Cardiac Surgery Procedure in a Patient with Multiple Myeloma:Report of a Case]Masashi Kano, Hironobu Shibata, Yuya Hiroshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 24, 2014
[Rapidly progressive AL amyloidosis in a patient with relapsed multiple myeloma after achieving a complete response to tandem autologous PBSCT]Hikaru Yagi, Shuji Ozaki, Etsuko Sekimoto, et al.
International Journal of Hematology|October 13, 2019
Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand diseaseToshio Shigekiyo, Hikaru Yagi, Etsuko Sekimoto, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2014
Antithrombin-p.Ala416Pro: the second reported case in JapanToshio Shigekiyo, Etsuko Sekimoto, Hironobu Shibata, et al.
British Journal of Haematology|March 16, 2004
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myelomaToshihiro Hashimoto, Masahiro Abe, Takashi Oshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis]Chihiro Shirai, Makiko Mizuguchi, Tomoko Maruhashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy]Takeshi Kageyama, Makiko Mizuguchi, Yasunobu Okamoto, et al.
Ejhaem|May 19, 2023
Systemic osteosclerosis associated with primary bone marrow B-cell lymphomaShuji Ozaki, Tsutomu Iima, Etsuko Sekimoto, et al.
Blood|July 23, 2005
Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myelomaAli Jalili, Shuji Ozaki, Tomoko Hara, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2018
[Azacitidine treatment for acute myeloid leukemia with myelodysplasia-related changes during peritoneal dialysis]Takashi Omatsu, Kengo Udaka, Hironobu Shibata, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|August 29, 2024
[Aortic Valve Replacement Using Minimally Invasive Cardiac Surgery Procedure in a Patient with Multiple Myeloma:Report of a Case]Masashi Kano, Hironobu Shibata, Yuya Hiroshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 24, 2014
[Rapidly progressive AL amyloidosis in a patient with relapsed multiple myeloma after achieving a complete response to tandem autologous PBSCT]Hikaru Yagi, Shuji Ozaki, Etsuko Sekimoto, et al.
International Journal of Hematology|October 13, 2019
Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand diseaseToshio Shigekiyo, Hikaru Yagi, Etsuko Sekimoto, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2014
Antithrombin-p.Ala416Pro: the second reported case in JapanToshio Shigekiyo, Etsuko Sekimoto, Hironobu Shibata, et al.
British Journal of Haematology|March 16, 2004
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myelomaToshihiro Hashimoto, Masahiro Abe, Takashi Oshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis]Chihiro Shirai, Makiko Mizuguchi, Tomoko Maruhashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy]Takeshi Kageyama, Makiko Mizuguchi, Yasunobu Okamoto, et al.
Ejhaem|May 19, 2023
Systemic osteosclerosis associated with primary bone marrow B-cell lymphomaShuji Ozaki, Tsutomu Iima, Etsuko Sekimoto, et al.
Blood|July 23, 2005
Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myelomaAli Jalili, Shuji Ozaki, Tomoko Hara, et al.
Pageof 3